Drug intelligence / Profile preview

prasterone enantate

Development stage
Unknown
Lead developer
Bayer HealthCare Pharmaceuticals
Modality
Small Molecules
Administration
Intramuscular
01

Overview

Prasterone enantate is a synthetic steroid ester and a long-lasting prodrug of prasterone (dehydroepiandrosterone, DHEA), administered primarily by intramuscular injection. It acts as a weak androgen, estrogen, and neurosteroid. In the body, it is hydrolyzed to release active prasterone, which can be further metabolized into both androgens and estrogens. Prasterone exerts its effects mainly through agonism of androgen and estrogen receptors after conversion to more potent sex steroids such as testosterone or estradiol. It is indicated for hormone replacement therapy in postmenopausal women to treat menopausal symptoms such as moderate to severe dyspareunia due to vulvar and vaginal atrophy[1][2][4][5][6]. The drug has an extended duration of action (about 18 days per injection) due to its depot formulation. Prasterone also exhibits neurosteroid activity with potential effects on mood regulation and cognitive function[6]. Side effects may include symptoms of masculinization in women.

Brand names
Gynodian Depot
Other names
prasterone enanthatedehydroepiandrosterone enanthateDHEA enantate
02

Targets

ESR1 (ERα)ESR2 (ERβ)AR (Adrenergic receptors)

Beyond the preview

Go deeper on prasterone enantate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on prasterone enantate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call